|
US2016235817A1
|
|
Acth for treatment of amyotrophic lateral sclerosis
|
|
US2014336104A1
|
|
ACTH prophylactic treatment of renal disorders
|
|
WO2014153221A2
|
|
Acth for treatment of acute respiratory distress syndrome
|
|
US2014294923A1
|
|
Acth for treatment of migraine headache
|
|
US7608616B1
|
|
Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
|
|
US2008279784A1
|
|
Nasal administration of benzodiazepines
|
|
US2008021074A1
|
|
Pharmaceutical Compositions and Related Methods of Treatment
|
|
WO0228829A2
|
|
Peptide deformylase inhibitors
|
|
US6770262B2
|
|
Nasal administration of agents for the treatment of gastroparesis
|
|
AU1929301A
|
|
Methods of use of peptide deformylase inhibitors as novel antibacterial agents
|
|
WO0114334A1
|
|
Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury
|
|
AU2176200A
|
|
Novel fungal mrna capping enzymes, and methods of using the same
|
|
US6251898B1
|
|
Medical use of fluorenone derivatives for treating and preventing brain and spinal injury
|
